Relationship between SARS-CoV-2 and hearing loss: A mini-review
Proceedings of Singapore Healthcare
; 31(no pagination), 2022.
Article
in English
| EMBASE | ID: covidwho-2232353
ABSTRACT
The most reported symptoms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were initially fever, dry cough, and sore throat. However, as we continue to review the literature, the loss of taste and smell were also added as clinical symptoms of the novel SARS-CoV-2. At present, the effects of SARS-CoV-2 on the auditory system is still not well-understood. This study is mini-review and aims to find out more about the relationship between SARS-CoV-2 and hearing loss through review of the literature. From our findings, hearing loss is the primary otological symptom of SARS-CoV-2, followed by tinnitus and dizziness. In conclusion, SARS-CoV-2 may have an effect on our auditory system, but due to the small sample sizes in the existing literature, further prospective studies are warranted to determine the relationship between the virus and hearing loss. Copyright © The Author(s) 2022.
covid-19; SARS-CoV-2; ssnhl; tinnitus; ageusia; anosmia; article; auditory system; cochlear hair cell; cochlear nerve; controlled study; coronavirus disease 2019; Cytomegalovirus; distortion product otoacoustic emission; dizziness; dry cough; fever; hair cell (inner ear); hearing impairment/dt [Drug Therapy]; human; nasopharyngeal swab; outer hair cell; perception deafness; pure tone audiometry; quality of life; randomized controlled trial (topic); reverse transcription polymerase chain reaction; sensitivity analysis; Severe acute respiratory syndrome coronavirus 2; sore throat; sudden deafness; systematic review; angiotensin converting enzyme 2/ec [Endogenous Compound]; corticosteroid/cb [Drug Combination]; corticosteroid/dt [Drug Therapy]; corticosteroid/po [Oral Drug Administration]; dexamethasone/cb [Drug Combination]; dexamethasone/dt [Drug Therapy]; favipiravir/dt [Drug Therapy]; hydroxychloroquine/dt [Drug Therapy]; hydroxychloroquine/po [Oral Drug Administration]; methylprednisolone/cb [Drug Combination]; methylprednisolone/dt [Drug Therapy]; prednisolone/cb [Drug Combination]; prednisolone/dt [Drug Therapy]; prednisolone/po [Oral Drug Administration]; transient evoked otoacoustic emission
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Language:
English
Journal:
Proceedings of Singapore Healthcare
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS